METHOCARBAMOL

Generic: METHOCARBAMOL

FH2 PHARMA LLCManufacturer
ORALRoute
METHOCARBAMOLActive Substance
2023-06-12Original Approval

METHOCARBAMOL is FDA application ANDA212707, sponsored by MIKART. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Recalls

Class II2025-03-21
Methocarbamol Injection USP 1,000 mg/10 mL (100 mg/mL), 10 mL Single Dose Vial, Rx Only, Manufactured for: Somerset Ther

Lack of Assurance of Sterility: Media fill with bacterial contamination

Class I2024-02-15
Methocarbamol Injection, USP 1000mg/10mL, (100mg/mL), 10 mL Single-Dose Vial packed 25 vials per carton, Rx Only, Mfd. i

Presence of Particulate Matter

Top Reported Reactions

1
FATIGUE
1,222 reports
2
PAIN
1,210 reports
3
NAUSEA
1,157 reports
4
DRUG INEFFECTIVE
1,094 reports
5
HEADACHE
935 reports
6
DIARRHOEA
839 reports
7
FALL
796 reports
8
OFF LABEL USE
790 reports
9
DYSPNOEA
759 reports
10
ARTHRALGIA
738 reports